LTFU-STITCH: Suture Techniques to Reduce the Incidence of Incisional Hernia: LTFU STITCH Trial

Sponsor
Erasmus Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT06066385
Collaborator
Franciscus &Vlietland (Other), Elisabeth-TweeSteden Ziekenhuis (Other), Rijnstate Hospital (Other), Spaarne Gasthuis (Other), Meander Medisch Centrum (Other), Red Cross Hospital Beverwijk (Other)
560
9
2
14
62.2
4.4

Study Details

Study Description

Brief Summary

Rationale: Incisional hernias (IH) are a frequent complication after abdominal surgery. Prevalence of an IH varies depending on the previous abdominal procedure but could be as high as 70% in high-risk patients after open surgery. To investigate different fascia closure techniques in the prevention of IHs, the STITCH trial (NCT01132209) was designed. The study compared two different closure techniques for closure of a midline incision in adult patients undergoing an elective abdominal laparotomy. Patients were randomly assigned to the intervention group (small bites 5 mm x 5 mm) or the control group (large bites 1 cm x 1 cm). The study showed that small bites are much more effective than large bites in the prevention of an incisional hernia when closing a midline incision.

So far, it has not been studied whether there is still a long-term difference in incidence of incisional hernia between the small bites and the large bites group.

Objective: The primary objective of this study is to determine the difference in incidence of IH between the small bites and the large bites group after 10 years of follow-up from time of randomization in the STITCH trial. The secondary objectives are to measure quality of life (QoL), body image and cosmetic results, and abdominal wall function through questionnaires and physical examination in those patients who are still alive.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Small bites technique
  • Procedure: Conventional large bites closure
N/A

Detailed Description

Rationale: Incisional hernias (IH) are a frequent complication after abdominal surgery. Prevalence of an IH varies depending on the previous abdominal procedure but could be as high as 70% in high-risk patients after open surgery. To investigate different fascia closure techniques in the prevention of IHs, the STITCH trial (NCT01132209) was designed, a randomized controlled trial in which 560 patients were included between October 2009 and March 2012. The study compared two different closure techniques for closure of a midline incision in adult patients undergoing an elective abdominal laparotomy. Patients were randomly assigned to the intervention group (small bites 5 mm x 5 mm) or the control group (large bites 1 cm x 1 cm). It showed that small bites are much more effective than large bites in the prevention of an incisional hernia when closing a midline incision.

So far, it has not been studied whether there is still a long-term difference in incidence of incisional hernia between the small bites and the large bites group.

Objective: The primary objective of this study study is to determine the difference in incidence of IH between the small bites and the large bites group after 10 years of follow-up from time of randomization in the STITCH trial. The secondary objectives are to measure quality of life (QoL), body image and cosmetic results, and abdominal wall function through questionnaires and physical examination in those patients who are still alive.

Study design: Assessment of long-term follow-up (10-13 years) of a randomized controlled multicenter study based on retrospective review of patient files and relevant imaging of the entire trial population, as well as questionnaires and physical and radiological examination of patient who are still alive.

Study population: Of the 560 included patients in the original STITCH trial, 545 completed the 1-year follow-up.

Intervention (if applicable): Not applicable. Main study parameters/endpoints: The primary outcome measure is the 10-year midline incisional hernia rate. The primary endpoint will be determined for the 545 patients of the original intention-to-treat population using Kaplan Meier analysis. In patients who died during follow-up, this will be evaluated by reviewing the available medical charts and radiological studies. CT-scans of the abdomen will be evaluated by the study-team. If CT imaging is not available, documented findings during physical examination by the relevant medical specialist will be considered. Patients being still alive with written informed consent to be contacted will be approached for their willingness to participate in this follow-up study, and after consent, we will reassess CT scans for an incisional hernia. All patients who are still alive and want to participate in this study will be asked to visit the hospital once for physical examination and an ultrasound of the abdominal wall.

Secondary outcome parameters include QoL and cosmetic outcome, Patients still alive with consent for participation will be sent the following questionnaires: MOS SF-36 and EQ-5D (QoL), Dresden Body Image Questionnaire (body image), Body Image Questionnaire (cosmesis), Hernia-Related Quality of Life Survey (abdominal wall function). Furthermore, readmission and surgical intervention rates related to midline IH will be determined for the entire study population.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Undergoing an ultrasound, physical examination and completing several questionnaires may be considered burdensome for the patient.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
560 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A Long-term follow-up with Outcome Assesor blinding of a parallel assigned double blinded (Participant, Investigator) Randomised Controlled trialA Long-term follow-up with Outcome Assesor blinding of a parallel assigned double blinded (Participant, Investigator) Randomised Controlled trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Outcome assessors of previous radiological imaging and imaging created during our Long-term follow up will be blinded to the assigned randomization arm.
Primary Purpose:
Treatment
Official Title:
Suture Techniques to Reduce the Incidence of Incisional Hernia After Midline Laparotomy; Long-Term Follow-Up of the STITCH Trial
Actual Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Small bites suturing technique of the abdominal wall during midline laparotomy

In the experimental group of 288 patients the small bites technique was applied with bite widths of 0,5 cm and inter suture spacing of 0,5 cm with the use of PDS plus ll 2-0 single suture material with a 31 mm needle placed in the linea alba. In the small bites technique, twice as many stitches will be placed per sutured cm, with a smaller needle and thinner suture material.

Procedure: Small bites technique
Closure of the fascia after midline laparotomy using a slowly resorbalbe 2.0 suture, with 0.5 cm bites, and 0.5 cm between the stitches, at least resulting in a 1:4 wound length:suture length ratio.

Active Comparator: Large bites suturing technique of the abdominal wall during midline laparotomy

As control the conventional large bites technique (mass closure) was applied with bites widths of 1 cm and inter-suture spacing of 1 cm with the use of PDS plus ll 1-0 double loop suture material with a 48 mm needle.

Procedure: Conventional large bites closure
Closure of a midline laparotomy using a slowy resorbable thick suture (e.g. PDS loop) with large bites and large steps (>= 1 cm).

Outcome Measures

Primary Outcome Measures

  1. Incisional hernia occurrence (and timeto incisional hernia outcome). [Patients will have a follow-up of up to 12 years, with most patients having a follow-up between 10 and 12 years.]

    Incisional hernia occurrence after operation clinical and/or radiological diagnosis.

Secondary Outcome Measures

  1. Quality of life of the patient. [Patients will have a follow-up of more than 10 years.]

    Quality of life measured by MOS SF-36, ranging from 0 (worst) to 100 (best).

  2. Quality of life of the patient. [Patients will have a follow-up of up to 12 years.]

    Quality of life measured by and EQ-5D, ranging from 0 (worst) to 100 (best).

  3. Body image. [Patients will have a follow-up of up to 12 years.]

    Body image measured by Dresden Body Image Questionnaire (DBIQ), consisting of 35 questions that can be answered with a yes or no. This results in a range of 0 (worst) to 35 (best) points.

  4. Cosmetic results, cosmesis. [Patients will have a follow-up of up to 12 years.]

    Cosmetic results measured by Body Image Questionnaire (BIQ), consisting of 10 questions with a score ranging from 10 (worst) to 64 (best) points.

  5. AWF. [Patients will have a follow-up of up to 12 years.]

    Hernia-Related Quality of Life Survey (HerQLes), with 12 questions ranging from 12 (worst) to 72 (best) points.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

In order to be eligible to participate in this study, a subject must meet the following criteria:

  • Available signed informed consent form for the original STITCH trial of the patients who are still alive.

  • Or if the patients has died, the medical records are reviewed.

A potential subject who meets the following criteria will be excluded from participation in this study:

  • Patients that on the original informed consent form of the STITCH trial, checked the box that they did not want to be approached for future follow-up studies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erasmus MC Rotterdam South-Holland Netherlands 3015
2 Meander Medical Center Amersfoort Netherlands
3 Rijnstate ziekenhuis Arnhem Netherlands
4 Red Cross Hospital Beverwijk Netherlands
5 Groene Hart Ziekenhuis Gouda Netherlands
6 Spaarne Gasthuis Haarlem Netherlands
7 Franciscus Gasthuis & Vlietland Rotterdam Netherlands
8 Prior Havenziekenhuis patients currently in the Erasmus MC Rotterdam Netherlands
9 Elisabeth-TweeSteden Ziekenhuis Tilburg Netherlands

Sponsors and Collaborators

  • Erasmus Medical Center
  • Franciscus &Vlietland
  • Elisabeth-TweeSteden Ziekenhuis
  • Rijnstate Hospital
  • Spaarne Gasthuis
  • Meander Medisch Centrum
  • Red Cross Hospital Beverwijk

Investigators

  • Principal Investigator: Pieter J Tanis, Erasmus Medical Center

Study Documents (Full-Text)

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Prof. dr. Pieter J Tanis, Prof.dr. P.J. Tanis, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT06066385
Other Study ID Numbers:
  • 9354
  • IIS WC-2022-06
  • MEC 2022-0652
First Posted:
Oct 4, 2023
Last Update Posted:
Oct 4, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prof. dr. Pieter J Tanis, Prof.dr. P.J. Tanis, Erasmus Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2023